Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Arad

Showing results (31-40 of 144) with videos related to

Pageof 15
Sort By:
The American Journal of Cardiology|June 22, 2019
Differences in Mortality of New-Onset (De-Novo) Acute Heart Failure Versus Acute Decompensated Chronic Heart FailureAnan Younis, Wesam Mulla, Ronen Goldkorn, et al.
European Journal of Preventive Cardiology|August 10, 2013
Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation centerRobert Klempfner, Tamir Kamerman, Ehud Schwammenthal, et al.
Biomed Research International|November 6, 2015
Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal DialysisMargarita Kunin, Vered Carmon, Michael Arad, et al.
The Israel Medical Association Journal : IMAJ|August 30, 2014
Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathyMichael Arad, Tamar Nussbaum, Ido Blechman, et al.
Experimental Cell Research|October 26, 2018
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axisMaayan Waldman, Vadim Nudelman, Asher Shainberg, et al.
Biochemical Pharmacology|August 19, 2009
Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damageAvishag K Emanuelov, Asher Shainberg, Yelena Chepurko, et al.
Heart Rhythm|June 29, 2023
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcomeAmitai Segev, Yishay Wasserstrum, Michael Arad, et al.
The Israel Medical Association Journal : IMAJ|March 9, 2026
Clinical Features and Outcomes of Acute Myocarditis in Patients with Swab-Confirmed Respiratory Viral PathogensWesam Mulla, Dafna Yahav, Anat Wieder, et al.
Experimental Cell Research|November 26, 2016
Caloric restriction ameliorates cardiomyopathy in animal model of diabetesKeren Cohen, Maayan Waldman, Nader G Abraham, et al.
Frontiers in Pharmacology|February 4, 2020
The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular TachycardiaHanna Bueno-Levy, David Weisbrod, Dor Yadin, et al.
Pageof 15

Showing results (31-40 of 144) with videos related to

Sort By:
Pageof 15
The American Journal of Cardiology|June 22, 2019
Differences in Mortality of New-Onset (De-Novo) Acute Heart Failure Versus Acute Decompensated Chronic Heart FailureAnan Younis, Wesam Mulla, Ronen Goldkorn, et al.
European Journal of Preventive Cardiology|August 10, 2013
Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation centerRobert Klempfner, Tamir Kamerman, Ehud Schwammenthal, et al.
Biomed Research International|November 6, 2015
Inflammatory Biomarkers in Refractory Congestive Heart Failure Patients Treated with Peritoneal DialysisMargarita Kunin, Vered Carmon, Michael Arad, et al.
The Israel Medical Association Journal : IMAJ|August 30, 2014
Prevalence and clinical predictors of reverse remodeling in patients with dilated cardiomyopathyMichael Arad, Tamar Nussbaum, Ido Blechman, et al.
Experimental Cell Research|October 26, 2018
PARP-1 inhibition protects the diabetic heart through activation of SIRT1-PGC-1α axisMaayan Waldman, Vadim Nudelman, Asher Shainberg, et al.
Biochemical Pharmacology|August 19, 2009
Adenosine A3 receptor-mediated cardioprotection against doxorubicin-induced mitochondrial damageAvishag K Emanuelov, Asher Shainberg, Yelena Chepurko, et al.
Heart Rhythm|June 29, 2023
Ventricular arrhythmias in patients with hypertrophic cardiomyopathy: Prevalence, distribution, predictors, and outcomeAmitai Segev, Yishay Wasserstrum, Michael Arad, et al.
The Israel Medical Association Journal : IMAJ|March 9, 2026
Clinical Features and Outcomes of Acute Myocarditis in Patients with Swab-Confirmed Respiratory Viral PathogensWesam Mulla, Dafna Yahav, Anat Wieder, et al.
Experimental Cell Research|November 26, 2016
Caloric restriction ameliorates cardiomyopathy in animal model of diabetesKeren Cohen, Maayan Waldman, Nader G Abraham, et al.
Frontiers in Pharmacology|February 4, 2020
The Hyperpolarization-Activated Cyclic-Nucleotide-Gated Channel Blocker Ivabradine Does Not Prevent Arrhythmias in Catecholaminergic Polymorphic Ventricular TachycardiaHanna Bueno-Levy, David Weisbrod, Dor Yadin, et al.
Pageof 15